658 related articles for article (PubMed ID: 25944389)
1. Deleterious versus protective autoimmunity in multiple sclerosis.
Kostic M; Stojanovic I; Marjanovic G; Zivkovic N; Cvetanovic A
Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389
[TBL] [Abstract][Full Text] [Related]
2. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
3. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.
Luchtman DW; Ellwardt E; Larochelle C; Zipp F
Cytokine Growth Factor Rev; 2014 Aug; 25(4):403-13. PubMed ID: 25153998
[TBL] [Abstract][Full Text] [Related]
4. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
Jadidi-Niaragh F; Mirshafiey A
Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
[TBL] [Abstract][Full Text] [Related]
5. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
6. B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Herold M; Posevitz V; Chudyka D; Hucke S; Groß C; Kurth F; Leder C; Loser K; Kurts C; Knolle P; Klotz L; Wiendl H
J Immunol; 2015 Oct; 195(8):3584-95. PubMed ID: 26378076
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo models of multiple sclerosis.
van der Star BJ; Vogel DY; Kipp M; Puentes F; Baker D; Amor S
CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):570-88. PubMed ID: 22583443
[TBL] [Abstract][Full Text] [Related]
8. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
Korn T; Mitsdoerffer M; Kuchroo VK
Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635
[TBL] [Abstract][Full Text] [Related]
9. Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis.
Zhang HL; Zheng XY; Zhu J
Cytokine Growth Factor Rev; 2013 Oct; 24(5):443-53. PubMed ID: 23791985
[TBL] [Abstract][Full Text] [Related]
10. ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
Aggelakopoulou M; Kourepini E; Paschalidis N; Panoutsakopoulou V
J Immunol; 2016 Jun; 196(12):4947-56. PubMed ID: 27183630
[TBL] [Abstract][Full Text] [Related]
11. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
12. T-cells in multiple sclerosis.
Severson C; Hafler DA
Results Probl Cell Differ; 2010; 51():75-98. PubMed ID: 19582415
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms regulating regional localization of inflammation during CNS autoimmunity.
Pierson E; Simmons SB; Castelli L; Goverman JM
Immunol Rev; 2012 Jul; 248(1):205-15. PubMed ID: 22725963
[TBL] [Abstract][Full Text] [Related]
14. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
Stinissen P; Raus J
Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
[TBL] [Abstract][Full Text] [Related]
15. Identification of a second mimicry epitope from Acanthamoeba castellanii that induces CNS autoimmunity by generating cross-reactive T cells for MBP 89-101 in SJL mice.
Massilamany C; Asojo OA; Gangaplara A; Steffen D; Reddy J
Int Immunol; 2011 Dec; 23(12):729-39. PubMed ID: 22058327
[TBL] [Abstract][Full Text] [Related]
16. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
[TBL] [Abstract][Full Text] [Related]
17. The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis.
Balasa R; Barcutean L; Balasa A; Motataianu A; Roman-Filip C; Manu D
Hum Immunol; 2020 May; 81(5):237-243. PubMed ID: 32122685
[TBL] [Abstract][Full Text] [Related]
18. Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.
Glatigny S; Duhen R; Arbelaez C; Kumari S; Bettelli E
Sci Rep; 2015 Jan; 5():7834. PubMed ID: 25592296
[TBL] [Abstract][Full Text] [Related]
19. Insights into the immunopathogenesis of multiple sclerosis.
Hellings N; Raus J; Stinissen P
Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
[TBL] [Abstract][Full Text] [Related]
20. miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3.
Zhu E; Wang X; Zheng B; Wang Q; Hao J; Chen S; Zhao Q; Zhao L; Wu Z; Yin Z
J Immunol; 2014 Jun; 192(12):5599-609. PubMed ID: 24842756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
